Saturday, December 06, 2025 | 10:55 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Between lab and jab: Miles to go before India has a Covid-19 vaccine

There is a reason why most of those involved in the race for a vaccine are studiously non-committal about a timeline

Coronavirus, vaccine, covid, drugs, tests, clinical trials
premium

As of now, three vaccine candidates are the front-runners in India: Zydus Cadila, Bharat Biotech and Serum Institute for the Oxford-AstraZeneca vaccine

Ruchika ChitravanshiSohini Das New Delhi/Mumbai
The quest for a Covid-19 vaccine may have started in the laboratories but that’s only the start of a long process that involves the government and private sector working on the other issues that bridge the gap from lab to jab — from manufacturing and manpower to logistics and distribution priorities.

That is why most of those involved in the race for a vaccine are studiously non-committal about a timeline. The 2020-end deadline that is being bandied about in the public domain is purely speculative.  
 
Balram Bhargava, chief of Indian Council of Medical Research, in a recent interview with Business